Join Paid Clinical Trials for Diarrhea in

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Diarrhea

Top of Directory » All Categories » by Illness » Diarrhea



  • Panitumumab and Irinotecan for Malignant Gliomas

    Condition:   Recurrent Grade IV Malignant Glioma
    Intervention:   Drug: Panitumumab in Combination with Irinotecan
    Sponsors:   Duke University;   Amgen
    Not yet recruiting - verified November 2009
  • A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

    Conditions:   Ulcerative Colitis;   Large Intestine;   Diarrhea;   Abdominal Pain
    Interventions:   Drug: LT-02;   Drug: placebo
    Sponsor:   Lipid Therapeutics GmbH
    Not yet recruiting - verified November 2009
  • Probiotics and the Prevention of Traveler's Diarrhea

    Condition:   Travelers' Diarrhea
    Interventions:   Dietary Supplement: Protecflor;   Dietary Supplement: Placebo
    Sponsors:   Lallemand SAS;   Sprim Italy
    Not yet recruiting - verified October 2009
  • Viusid in Adults With Acute Fever of Viral Etiology

    Condition:   Acute Fever of Viral Etiology
    Interventions:   Dietary Supplement: Viusid;   Drug: Conventional treatment
    Sponsor:   Catalysis SL
    Recruiting - verified November 2009
  • Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma

    Conditions:   Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
    Intervention:   Drug: Avastin in Combination with Radiation and Temozolomide followed by Avastin, Temozolomide, and Topotecan
    Sponsors:   Duke University;   Genentech;   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana

    Condition:   Anemia
    Interventions:   Dietary Supplement: Sprinkles®;   Dietary Supplement: vitamin/mineral fortificant without iron
    Sponsor:   The Hospital for Sick Children
    Not yet recruiting - verified October 2009
  • Effectiveness Comparison of Three Supplementary Foods in the Treatment of Moderate Acute Malnutrition

    Condition:   Malnutrition
    Interventions:   Dietary Supplement: Soy/peanut fortified spread;   Dietary Supplement: Milk fortified corn/soy blend;   Dietary Supplement: Supplementary Plumpy®
    Sponsor:   Washington University School of Medicine
    Not yet recruiting - verified October 2009
  • Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin

    Condition:   Diarrhoea
    Interventions:   Drug: Rifaximin;   Drug: Lactulose
    Sponsor:   University Hospital Tuebingen
    Recruiting - verified November 2009
  • A Pilot Study for Collection of Anti-Influenza A H1N1 (Swine Flu) Hyper-Immune Plasma

    Conditions:   H1N1 Influenza;   Swine Flu
    Intervention:  
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified August 2009
  • Swine Flu (Novel Influenza A H1N1) Vaccine Study

    Condition:   Influenza
    Interventions:   Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
    Sponsor:   University of Oxford
    Recruiting - verified October 2009
  • Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

    Condition:   Rotavirus Gastroenteritis
    Intervention:   Biological: Rotarix™
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome

    Condition:   Carcinoid Syndrome
    Interventions:   Drug: octreotide acetate;   Drug: octreotide implant
    Sponsor:   Endo Pharmaceuticals Solutions Inc.
    Recruiting - verified October 2009
  • Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

    Condition:   Shigella
    Interventions:   Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
    Sponsors:   University of Maryland;   Program for Appropriate Technology in Health
    Not yet recruiting - verified November 2009
  • A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

    Condition:   Advanced Non-Small Cell Lung Cancer
    Interventions:   Drug: Irinotecan;   Drug: Cisplatin;   Drug: TS-1 (S-1)
    Sponsors:   National Cancer Center, Korea;   Jeil Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009
  • Safety of Lactobacillus Reuteri in Healthy Volunteers

    Condition:   Healthy
    Interventions:   Biological: Lactobacillus reuteri;   Other: Placebo
    Sponsors:   Tulane University School of Medicine;   National Center for Complementary and Alternative Medicine (NCCAM);   Johns Hopkins Bloomberg School of Public Health;   Asociacion Benefica PRISMA;   US Naval Medical Research Center Detachment
    Not yet recruiting - verified November 2009
  • A Controlled Trial of Plantain Powder in Infantile Diarrhea

    Condition:   Diarrhea, Infantile
    Interventions:   Dietary Supplement: Green banana powder;   Other: Microcrystalline cellulose
    Sponsors:   Medical College of Georgia;   NRS Medical College, Kolkata, West Bengal, India;   School of Tropical Medicine, Kolkata, West Bengal, India
    Recruiting - verified October 2009
  • Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea

    Condition:   Chemotherapy-induced Diarrhea
    Intervention:   Drug: Octreotide Long Active Release
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009
  • Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

    Condition:   HIV Associated Diarrhea
    Interventions:   Drug: Placebo;   Drug: Crofelemer 125 mg;   Drug: Crofelemer 250 mg;   Drug: Crofelemer 500 mg
    Sponsor:   Salix Pharmaceuticals
    Recruiting - verified November 2009
  • Study of Rituximab to Treat Chronic Renal Transplant Rejection

    Conditions:   Kidney Transplantation;   Graft Rejection;   Immunosuppression
    Interventions:   Drug: Rituximab;   Other: Control arm
    Sponsors:   King's College London;   Medical Research Council;   Roche Pharma AG
    Recruiting - verified February 2009
    • Menu
    Find Paid Clinical Trials